GERMANTOWN, Md., Aug. 6 /PRNewswire-FirstCall/ -- Avalon Pharmaceuticals, Inc. (Nasdaq: AVRX - News), today announced the appointment of Bradley G. Lorimier as Chairman of the Board of Directors. He succeeds Alan G. Walton, Ph.D., D.Sc., who will stay on as a Director.
